Pharmaceutical / Drug Definition :
Cytotoxic effect may stem from inhibition of DNA polymerase by drug's active metabolite.
In the United States, Cytarabine is regulated by the U.S. Food and Drug Administration (FDA). FDA has specific requirements regarding the registration and listing of Cytarabine.
Registrar Corp assists Cytarabine companies with:
FDA Label Requirements and Exceptions
FDA Import Information
Cytarabine (Cytarabine Entry Refusal)
General U.S. Food and Drug Administration Guidelines for:
- Manufacturers Cytarabine (Cytarabine Suppliers)
- Processors Cytarabine
- Repackers Cytarabine
- Relabelers Cytarabine
- Exporters Cytarabine
- Importers Cytarabine
For more information about Cytarabine, simply click below:
U.S. FDA Regulations:
U.S. FDA Regulation: 21 C.F.R. Part 207
Registrar Corp assists businesses with U.S. FDA compliance. Certificates of Registration issued by Registrar Corp provide confirmation to industry that you are fulfilling U.S. FDA registration requirements. U.S. FDA does not issue or recognize Certificates of Registration. Registrar Corp is not affiliated with the U.S. Food and Drug Administration.